A lawyer for the Canadian maker of a cheap generic version of blood thinner Plavix urged a judge Monday to clear the way for its sale, saying Plavix was based on an invalid patent.

The lawyer, Robert Breisblatt, arguing on behalf of Apotex Inc., told U.S. District Judge Sidney H. Stein he should reverse his August decision to block sales of the generic drug.